HPV screening, self-sampling, and a global view on vaccination

Click here to view it online
Eurogin 2022 Logo
APRIL 10-12 | IN-PERSON EVENT
CONGRESS CENTER DÜSSELDORF, GERMANY
Dear Doctor,

The EUROGIN congress offers a full overview of current scientific developments in the field of cervical cancer and other HPV-related diseases control with a program informed by leading scientists. Learn how to apply these findings in clinical practice.
Join us for the EUROGIN conference in person.
border 00
PROGRAM HIGHLIGHTS

New evidence on the effectiveness of HPV vaccination against invasive cervical cancer:
a global view
Monday, 11 April 2022 • 16:00 - 18:00
Chairs: J. Z. Shing (USA) -  A. Kreimer (USA)
 
This session highlights the recent and novel global findings of HPV vaccine effectiveness against cervical cancer, a long-awaited research endpoint.
 
HPV screening in real life, the first experiences
Tuesday, 12 April 2022 • 15:15 - 16:45
Chairs: J. Bonde (Denmark) - S. Van Dijk (Netherlands)
 
Explore large scale data comparing current cytology to HPV screening as well as experience from HPV-primary screening across a range of countries.
 
TRAVELLING TO GERMANY IS EASY
Simply present one of the following upon entry:
 
✓ Proof of fully vaccinated status
✓ OR proof of recovery from COVID-19
✓ OR proof of negative PCR test no more than 48 hours old
 
If you are coming from a risk area, you are also required to complete the digital entry registration form beforehand.
Want to know more about safety measures available at the conference?
covid travel info
We look forward to welcoming you to the EUROGIN congress 2022
in Düsseldorf on April 10-12.
 
Kindest regards,
The EUROGIN team
 
FOR MORE INFORMATION
Contact us or email at: admin@eurogin.com
 
MORE INFORMATION ON

EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia), 174, rue de Courcelles, Paris, Île-de-France, 75017, France, https://www.eurogin.com

UNSUBSCRIBE